X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs GLENMARK PHARMA - Comparison Results

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE GLENMARK PHARMA TTK HEALTHCARE/
GLENMARK PHARMA
 
P/E (TTM) x 18.9 19.2 98.3% View Chart
P/BV x 2.2 3.4 65.3% View Chart
Dividend Yield % 0.8 0.3 243.2%  

Financials

 TTK HEALTHCARE   GLENMARK PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-18
GLENMARK PHARMA
Mar-18
TTK HEALTHCARE/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,458930 156.7%   
Low Rs795517 153.7%   
Sales per share (Unadj.) Rs408.7322.6 126.7%  
Earnings per share (Unadj.) Rs12.928.5 45.1%  
Cash flow per share (Unadj.) Rs23.639.2 60.3%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.40.3 160.6%  
Book value per share (Unadj.) Rs164.9183.0 90.1%  
Shares outstanding (eoy) m14.13282.17 5.0%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.82.2 122.8%   
Avg P/E ratio x87.625.4 344.8%  
P/CF ratio (eoy) x47.618.5 258.0%  
Price / Book Value ratio x6.84.0 172.7%  
Dividend payout %38.97.0 553.9%   
Avg Mkt Cap Rs m15,916204,206 7.8%   
No. of employees `0002.213.7 16.4%   
Total wages/salary Rs m1,09018,718 5.8%   
Avg. sales/employee Rs Th2,573.86,636.8 38.8%   
Avg. wages/employee Rs Th485.71,364.7 35.6%   
Avg. net profit/employee Rs Th81.0586.1 13.8%   
INCOME DATA
Net Sales Rs m5,77691,031 6.3%  
Other income Rs m76914 8.3%   
Total revenues Rs m5,85191,945 6.4%   
Gross profit Rs m42616,154 2.6%  
Depreciation Rs m1523,019 5.0%   
Interest Rs m472,856 1.7%   
Profit before tax Rs m30211,193 2.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1203,155 3.8%   
Profit after tax Rs m1828,039 2.3%  
Gross profit margin %7.417.7 41.5%  
Effective tax rate %39.728.2 141.0%   
Net profit margin %3.18.8 35.6%  
BALANCE SHEET DATA
Current assets Rs m2,55669,887 3.7%   
Current liabilities Rs m1,67532,879 5.1%   
Net working cap to sales %15.340.7 37.5%  
Current ratio x1.52.1 71.8%  
Inventory Days Days3381 41.1%  
Debtors Days Days3593 37.4%  
Net fixed assets Rs m1,10328,892 3.8%   
Share capital Rs m141282 50.1%   
"Free" reserves Rs m2,18851,353 4.3%   
Net worth Rs m2,33051,635 4.5%   
Long term debt Rs m741,418 0.0%   
Total assets Rs m4,073125,954 3.2%  
Interest coverage x7.44.9 149.9%   
Debt to equity ratio x00.8 0.4%  
Sales to assets ratio x1.40.7 196.2%   
Return on assets %5.68.6 65.0%  
Return on equity %7.815.6 50.1%  
Return on capital %14.915.1 98.9%  
Exports to sales %3.00-   
Imports to sales %0.60-   
Exports (fob) Rs m172NA-   
Imports (cif) Rs m35NA-   
Fx inflow Rs m17236,317 0.5%   
Fx outflow Rs m559,720 0.6%   
Net fx Rs m11726,598 0.4%   
CASH FLOW
From Operations Rs m25316,481 1.5%  
From Investments Rs m-226-10,133 2.2%  
From Financial Activity Rs m-72-4,685 1.5%  
Net Cashflow Rs m-411,770 -2.3%  

Share Holding

Indian Promoters % 65.4 48.3 135.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 6.9 53.6%  
FIIs % 5.2 34.4 15.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.5 245.7%  
Shareholders   12,723 56,727 22.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ABBOTT INDIA  NATCO PHARMA  BIOCON   PFIZER  MERCK  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Tata Steel and Axis Bank Top Gainers(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.7% while the Hang Seng is down 0.1%.

Related Views on News

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

GLENMARK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 11.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, GLENMARK PHARMA has posted a net profit of Rs 1 bn (up 11.1% YoY). Sales on the other hand came in at Rs 26 bn (up 15.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, GLENMARK PHARMA has posted a net profit of Rs 4 bn (up 93.3% YoY). Sales on the other hand came in at Rs 26 bn (up 14.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

More Views on News

Most Popular

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

The Best Trading Strategy in the World(Profit Hunter)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

L&T: Should Corporates have a Conscience?(The Honest Truth)

Apr 22, 2019

Ajit Dayal believes L&T is taking a risky path and risking not only the culture established at MindTree but the fragile eco system that could endanger the lives of millions of residents in Mumbai.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 24, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - CIPLA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS